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Summary An analysis of cytology reporting within Victorian Cytology Service demonstrates that the propor-
tion of Papanicolaou smears which were reported as including an endocervical component increased from
approximately one half during 1987-89 to more than three quarters during 1990-91. The improvement
coincided with the routine provision of special sampling instruments to all practitioners supplemented by an
education program. Despite the increase in endocervical sampling, no increase in the rate of reporting of
high-grade intraepithelial lesions of the cervix has occurred. An increase between the two time periods in the
cytological reporting of adenocarcinoma, adenocarcinoma in situ and endocervical dyskaryosis has occurred,
but does not reach statistical significance.
The late 1980s was a time when renewed emphasis was given
to the quality of the cell sample for cervical cytology speci-
mens. A number of studies had documented a higher abnor-
mality rate among smears which included an endocervical
component than among smears which were reported as lack-
ing an endocervical component (Elias et al., 1983; Laverty et
al., 1989; Mauney & Sotham, 1990; Vooijs et al., 1986). As a
consequence, many laboratories devoted considerable time
and resources to strategies aimed at increasing the proportion
of smears with an endocervical component.
In Australia it became routine for laboratories to provide
practitioners with sampling instruments which were speci-
fically designed to facilitate collecting an endocervical sample.
Practitioners were informed there were two reasons for the
change. First, a higher detection rate of abnormalities was
expected, hopefully reducing the false negative rate of screen-
ing. Second, improved detection of the precursors to adeno-
carcinoma was anticipated.
Victorian Cytology Service is the largest cytology
laboratory in Australia, reporting in excess of 250,000
Papanicolaou smears per year. Endocervical status has been
routinely reported on all smears since April 1987. During
1987 and 1988, an endocervical component was reported as
being present if either columnar or squamous metaplastic
cells were identified. In January 1989 more stringent criteria
were introduced requiring the identification of ten or more
endocervical cells singly and/or in small groups, or six or
more endocervical cells in a sheet for an endocervical compo-
nent to be reported as present.
Cytobrushes and cervix samplers have been routinely sup-
plied since December 1989. Practitioners received written
instructions that a cytobrush and spatula should be used
together for women of any age group (except pregnant
women) and that cervex samplers were a satisfactory single
sampling instrument for premenopausal women. In addition,
all practitioners received regular information sheets stressing
the importance of the cell sample and providing an illustrated
stey-by-step guide to optimal sampling techniques. A
physician was employed to personally visit those practices
which sought additional help. Visits targeted to practices
with low success rates in sampling endocervical cells were
made during 1990 and 1991.
This paper details our experience between 1987 and 1991.
The proportion of smears reported as including an endocer-
vical component has been correlated with the detection rate
of high-grade intraepithelial lesions and with the reporting of
abnormalities of the endocervix.
Methods
The proportion of smears reported as including an endocer-
vical component for each of the calendar years between 1987
and 1991 was determined from computerised records. Smears
which were reported as technically unsatisfactory (e.g. due to
inadequate fixation, heavy inflammatory infiltrate etc) or
were taken post-hysterectomy have been excluded.
The cytological reporting rate for high grade intraepithelial
lesions (moderate dyskaryosis, moderate/severe dyskaryosis,
severe dyskaryosis) of either squamous or adeno type was
determined for each year and stratified according to endocer-
vical status. As many women who receive these high grade
reports have repeated tests as part of their further investiga-
tions, this analysis was restricted to the first reported abnor-
mality in each year for each woman.
The rate of cytological reporting of endocervical dys-
karyosis, adenocarcinoma in situ and adenocarcinoma of the
cervix per 10,000 smears was calculated for the two time
periods, 1987-1989 and 1990-1991. These time groupings
correspond to periods where substantially different propor-
tions ofall smears were reported as including an endocervical
component.
All analyses of abnormality rates in this study were
confined to smears collected by general medical practitioners
and nurse practitioners and therefore represent disease rates
applicable to the general community. Smears collected by
gynaecologists were excluded for two related reasons. First,
in Australia smears collected by gynaecologists are frequently
taken in the context of gynaecological symptoms rather than
for screening purposes. (Women require a letter of referral
from a general practitioner to be able to claim the cost of a
visit to a gynaecologist from Medicare.) Artificial fluctuations
in abnormality rates can therefore occur depending on whether
or not gynaecologists routinely take smears from women
with symptoms and signs consistent with malignancy.
Second, during the period of this study the number of
gynaecologists whose smears were reported by the Victorian
Cytology Service declined as a result of a rapid expansion of
private pathology laboratories. Exclusion of smears collected
by gynaecologists was felt necessary to remove these ex-
traneous influences on abnormality rates.
Results
The proportion of smears in each year from 1987 to 1991
which were reported as including an endocervical component
is shown in Table I. While some fluctuation is evident, the
proportion has increased from around one half to more than
three quarters, with the major increase occurring between
1989 and 1990. This time period coincided with the introduc-
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tion of special sampling devices and the educational
initiatives for practitioners.
The rate of reporting of high grade abnormalities per
10,000 smears in each of the calendar years is shown in Table
II. With the exception of 1988, the rates are fairly stable. In
particular, there is no evidence of a direct increase during
1990-1991 when a higher proportion of smears were re-
ported as including an endocervical component. Among
smears with an endocervical component, there was a decrease
in the rate of reporting of each degree of high-grade intra-
epithelial abnormality between 1987-1989 and 1990-1991
(See Table IIIa). With the exception of CIN 3, no clear trend
was apparent in the abnormality rates among the group of
smears reported as not including an endocervical component
(See Table IlIb).
The ratio of high-grade abnormality rates among smears
with and without an endocervical component declined
throughout the period of this study from 5.9 (77.8/13.2) in
1987 to 2.4 (55.2/23.3) in 1991.
Table I Proportion of smears reported as including an endocervical
component by calendar year
Year Proportion
1987a 57%
1988 53%
1989 49%
1990 76%
1991 78%
aBased on April-December only.
The rate ofcytological reporting of adenocarcinoma of the
cervix and its precursors increased from 0.66 per 10,000
smears during 1987-1989 (95% confidence interval
0.46-0.86) to 1.06 per 10,000 smears during 1990-1991
(95% confidence interval 0.76-1.37). This increase was not
statistically significant.
Table II Rate of cytological reporting of high-grade intraepithelial abnormality per
10,000 smears by year
Rate per 10,000 smears
Severe, moderate/severe,
moderate dyskaryosis Severe Moderate/severe Moderate
Year (95% confidence interval) dyskaryosis dyskaryosis dyskaryosis
1987a 46.1 (42.8-49.4) 12.5 12.3 21.4
1988 71.7 (68.0-75.3) 19.1 21.5 31.1
1989 48.3 (45.2-51.3) 14.3 15.0 19.0
1990 50.2 (47.2-53.1) 15.3 15.2 19.7
1991 49.0 (46.1-52.0) 15.3 13.6 20.1
aBased on April-December only.
Table III Rate of cytological reporting of high-grade intraepithelial abnormality per
10,000 smears by year
(a) Among smears which were reported as including an endocervical component
Severe, moderate/severe, Severe Moderate/severe Moderate
moderate dyskaryosis dyskaryosis dyskaryosis dyskaryosis
1987a 77.8 21.8 21.7 34.4
1988 102.6 27.9 31.3 43.4
1989 68.6 21.1 21.2 26.3
1990 56.5 17.3 16.9 22.3
1991 55.2 17.4 15.5 22.4
(b) Among smears which were reported as not including an endocervical component
Severe, moderate/severe, Severe Moderate/severe Moderate
moderate dyskaryosis dyskaryosis dyskaryosis dyskaryosis
1987a 13.2 2.5 2.2 8.4
1988 24.7 5.9 6.9 11.9
1989 22.5 5.7 7.3 9.4
1990 23.2 7.0 7.0 9.3
1991 23.3 7.0 6.1 10.2
aBased on April-December only.
Table IV Number and proportion of all smears reported as unsatisfactory for
assessment, 1987-1991
1987
1988
1989
1990
1991
Number of smears Number (%) reported Number (%) with
received as unsatisfactory insufficient squamous cells
262,721 1170 (0.45%) 682 (0.26%)
252,950 1446 (0.57%) 843 (0.33%)
238,164 1091 (0.46%) 624 (0.26%)
255,836 883 (0.35%) 538 (0.21%)
256,419 771 (0.30%) 463 (0.18%)ABNORMALITIES BY ENDOCERVICAL STATUS 587
Discussion
The observation from cross-sectional studies that a higher
abnormality rate is reported among smears which include an
endocervical component than among smears which lack an
endocervical component has two possible explanations. The
presence of an endocervical component could be either a
marker of a group of women who are at higher risk of
abnormality (possibly due to an exposed transformation zone
or to reduced cell adhesiveness in the presence of disease) or,
alternatively, the presence of an endocervical component
could be a marker for a high quality smear such that a more
comprehensive detection of abnormalities occurred.
This study, based on an analysis of more than one million
Papanicolaou smears reported over 5 years, has shown that
despite a very substantial increase in the proportion of
smears with an endocervical component, no commensurate
increase in the reporting of high-grade intraepithelial lesions
of the cervix occurred. The declining ratio of reported abnor-
malities in smears with and without an endocervical compo-
nent indicates a weakening of the relationship between
endocervical status and the probability of an abnormality
being reported. These findings suggests that the more likely
explanation of the association between endocervical compo-
nent and higher abnormality rate was that a relatively easily
sampled endocervical component was a marker of women
who were at higher risk of abnormality.
A number of randomised trials have recently been con-
ducted evaluating different sampling instruments with the
outcome measure of interest being the rate of cytological
reporting of dyskaryosis. Four randomised trials (Goorney et
al., 1989; Buxton et al., 1990; Selvaggi & Malviya, 1991;
Szarewski et al., 1990) have demonstrated an increase in the
proportion of smears with an endocervical component but no
commensurate increase in the detection of intraepithelial
abnormalities. Wolfendale et al. (1987) showed an increase in
the sampling ofendocervical material and, while a increase in
the crude rate of reporting of dyskaryotic smears was noted,
when account was taken of the design of the study, no
statistically significant increase in the detection of abnor-
malities was found. Overall the findings from these ran-
domised trials support the findings of this current study; that
is, that there may not be a commensurate increase in the
reporting of intraepithelial abnormalities despite an increase
in the endocervical sampling rate. Conclusions by Boon et al.
(1989) about higher detection rates of intraepithelial neo-
plasia with different sampling instruments have been con-
sidered invalid by Sasieni (1991, 1992) because of flawed
statistical analyses.
Over the time period of this study, the age of the women
being screened by VCS did not alter to any appreciable
extent; 82%-84% of smears in each year were received from
women under 50 years of age. Similarly there is no evidence
that the failure to show an increased reporting of high grade
intraepithelial abnormalities was due to a decline in the
quality of the sample of the anatomical ectocervix. Table IV
shows the proportion of all smears which were reported as
unsatisfactory for assessment in each of the calendar years of
this study plus gives details of the number of smears which
were reported as being unsatisfactory because of insufficient
squamous cells. The data show that the proportion of smears
reported as being unsatisfactory has declined over the period
of this study.
The introduction of the new sampling instruments and the
educational program for practitioners was not without cost,
both in financial terms and in the use of human resources.
Substantial efforts were needed to inform practitioners about
how to collect a Papanicolaou smear using two instruments
without suffering a deterioration in the quality of the speci-
men; cervical cells deteriorate rapidly after collection and
there was a need to ensure that the fixation of both speci-
mens was adequate. Many practitioners wished to use two
glass slides, one for each specimen. This was considered
highly undesirable as it would result in a doubling of the
number of slides to be processed.
From the laboratory's viewpoint, the new policy had a
number of effects. An internal retraining program was neces-
sary for cytologists as they were unfamiliar with the full
range of appearances of endocervical samples obtained using
a brush. Even the requirement that all specimens have their
endocervical status reported was associated with a slowing of
work throughput. Perhaps more intangibly there was a dis-
ruption to the general level of confidence among the
cytologists which was particularly apparent during 1988. The
fact that other laboratories were reporting very much high
proportions of all smears as including an endocervical com-
ponent raised concerns about the false negative rate among
our numerically large group of smears which lacked an
endocervical component. In addition VCS cytologists were
aware that other laboratories were reporting up to 15% of
their smears as showing evidence of human papillomavirus
effect; the comparable figure within VCS was approximately
4%. These concerns resulted in a change in reporting practice
whereby more minor changes were reported as abnormal
which would previously have been regarded as being within
normal limits. These uncertainties probably account for the
statistics for 1988 being noticeably different to the general
trend. By 1989 the laboratory had, to a large extent, resumed
its more long-standing profile of reporting (Mitchell &
Medley, 1990).
Clearly the two reasons for advocating the change in
policy to practitioners have not been fulfilled. The increase in
the reporting of endocervical abnormalities may be clinically
important but does not yet reach statistical significance.
Adenocarcinoma of the cervix is a rare disease among the
premenopausal age group which comprises the majority of
participants in the screening program in Australia (Free et
al., 1991). We have previously shown that the sensitivity of
cervical cytology for the detection of adenocarcinoma is less
than for squamous carcinoma (Mitchell et al., 1988). A
worthwhile benefit of the changed policies will be if the
accuracy of predicting disease of the endocervix improves,
particularly the detection of endocervical dyskaryosis and
adenocarcinoma in situ. Continued monitoring in these areas
is occurring.
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